TP53 and breast cancer: Our results revealed a number of associations for breast cancer lymph node metastasis, such as non-synonymous mutation burden, neoantigen burden, significantly different gene mutation rates, mutation hotspot distribution on TP53, tumor heterogeneity, neoantigen origin proteins and differentially expressed genes.